It’s Domestic Violence Awareness Month, and a tragic case illustrates how quickly violence can invade a relationship. Krystal ...

Third Quarter 2024 Results Key Financial Results Revenue: US$83.8m (up by US$75.3m ...

Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the Guggenheim Securities Healthcare Innovation ...

November 4, 2024Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $0.909, expectations were $0.9. Operator: Thank you for standing by and welcome to Krystal Biotech's Third Quarter ...

Krystal Biotech (KRYS) has received a new Buy rating, initiated by William Blair analyst, Sami Corwin. Sami Corwin has given his Buy rating due ...

In July, Krystal franchisee WAC Enterprises opened its 92nd location in Arab, Alabama, a community with a population under ...

Krystal, the original home of the slider in the South, is turning up the heat this holiday season with limited-time menu offerings that blend bold flavors with seasonal nostalgia. Beginning Oct. 28, ...

RuPaul's Drag Race UK winner Krystal Versace has announced a break from drag. Krystal won the third season of the BBC's drag ...

Krystal Aziz, Modern Travelworks & Trazel 0 0 0 AM 74 false false 1089 true true false [--image id='1'--]Bio  Krystal Aziz ...

Krystal Rosa has a commitment to helping students in Dayton find success and continue their education after high school. She ...

英为财情Investing.com - Krystal Biotech (NASDAQ: KRYS )星期一发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益低于分析师的预期。 在该公司发布的最新财报中，公司每股收益为$0.91，总营收为$83.8M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$82.94M，每股收益为$0.99.

Chardan Capital analyst Geulah Livshits has reiterated their bullish stance on KRYS stock, giving a Buy rating yesterday. Geulah Livshits has ...